Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Bardakjian, Tanya M.a; 1 | Klapper, Jennifera; 1 | Carey, Adriannab | Wood, Juliab | Pauly, Meredithb | Gasper, Kellyb | Lawler, Kathya | Tran, Baochana | Bell, Yuliisa | Zwil, Alexc | Gonzalez-Alegre, Pedroa; *
Affiliations: [a] Department of Neurology, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA | [b] Dan Aaron Parkinson’s Disease Rehabilitation Center, University of Pennsylvania Health System, Pennsylvania Hospital, Philadelphia, PA, USA | [c] Department of Psychiatry, Perelman School of Medicine, The University of Pennsylvania, Philadelphia, PA, USA
Correspondence: [*] Correspondence to: Pedro Gonzalez-Alegre, MD, PhD, Pennsylvania Neurological Institute, 330 S. 9th Street, Philadelphia, PA 19107, USA. E-mail: [email protected].
Note: [1] These authors contributed equally to this work.
Abstract: Background:Clinical care for Huntington’s disease (HD) is often provided in experienced centers that provide multidisciplinary care. However, the value of these centers and their uptake by HD families remain unknown. Objective:To describe the services provided by a new HD center, including estimates of capture of the population served. Methods:Retrospective review of a HD Center launched in 2015, including quantitative and qualitative data on clinic visits, demographic and clinical data. Results:We observed a rapid and ongoing growth on the annual number of clinic encounters, with high demand for in-clinic multidisciplinary care. Using census data and estimates of HD prevalence, we determined that we served about 20% of local patients with HD. Most HD patients received pharmacological treatment for psychiatric symptoms, and over half were treated for chorea. About 25% of new HD diagnoses were on patients without family history of HD. Finally, the demand for predictive testing in at risk individuals significantly increased following the press release reporting the successful completion of the Ionis-HTTRx (RG 6042) trial. Conclusions:This report indicates a high demand for multidisciplinary care by HD families, supporting its value, providing a snapshot of the organization and function of a single center. Furthermore, it demonstrates how dissemination of news related to research advances influence clinical behavior. Reporting similar information from other HD centers to would provide us with a more global view of the status of HD care across multiple geographical areas.
Keywords: Multidisciplinary, Huntington’s disease, outcomes, health services
DOI: 10.3233/JHD-190355
Journal: Journal of Huntington's Disease, vol. 8, no. 4, pp. 501-507, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]